{"pmid":32381561,"title":"Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.","text":["Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.","Ann Rheum Dis","Konig, Maximilian F","Kim, Alfred Hj","Scheetz, Marc H","Graef, Elizabeth R","Liew, Jean W","Simard, Julia","Machado, Pedro M","Gianfrancesco, Milena","Yazdany, Jinoos","Langguth, Daman","Robinson, Philip C","32381561"],"journal":"Ann Rheum Dis","authors":["Konig, Maximilian F","Kim, Alfred Hj","Scheetz, Marc H","Graef, Elizabeth R","Liew, Jean W","Simard, Julia","Machado, Pedro M","Gianfrancesco, Milena","Yazdany, Jinoos","Langguth, Daman","Robinson, Philip C"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381561","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/annrheumdis-2020-217690","keywords":["epidemiology","hydroxychloroquine","lupus erythematosus, systemic","pharmacokinetics"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666267276711559168,"score":9.490897,"similar":[{"pmid":32475831,"title":"Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.","text":["Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.","Ann Rheum Dis","Carbillon, Lionel","Benbara, Amelie","Boujenah, Jeremy","32475831"],"journal":"Ann Rheum Dis","authors":["Carbillon, Lionel","Benbara, Amelie","Boujenah, Jeremy"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475831","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/annrheumdis-2020-217847","keywords":["autoimmunity","epidemiology","hydroxychloroquine","immune complex diseases","lupus erythematosus, systemic"],"topics":["Treatment"],"weight":1,"_version_":1668437835056676864,"score":111.106186},{"pmid":32398281,"title":"COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.","text":["COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.","Ann Rheum Dis","Bozzalla Cassione, Emanuele","Zanframundo, Giovanni","Biglia, Alessandro","Codullo, Veronica","Montecucco, Carlomaurizio","Cavagna, Lorenzo","32398281"],"journal":"Ann Rheum Dis","authors":["Bozzalla Cassione, Emanuele","Zanframundo, Giovanni","Biglia, Alessandro","Codullo, Veronica","Montecucco, Carlomaurizio","Cavagna, Lorenzo"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398281","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/annrheumdis-2020-217717","keywords":["epidemiology","hydroxychloroquine","lupus erythematosus, systemic"],"locations":["northern-Italian"],"topics":["Prevention"],"weight":1,"_version_":1666714494792892416,"score":101.970406},{"pmid":32475834,"title":"Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.","text":["Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.","Ann Rheum Dis","Konig, Maximilian F","Gianfrancesco, Milena","Yazdany, Jinoos","Robinson, Philip C","32475834"],"journal":"Ann Rheum Dis","authors":["Konig, Maximilian F","Gianfrancesco, Milena","Yazdany, Jinoos","Robinson, Philip C"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475834","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/annrheumdis-2020-217990","keywords":["epidemiology","hydroxychloroquine","lupus erythematosus, systemic"],"weight":0,"_version_":1668437834961256448,"score":100.75765},{"pmid":32451344,"title":"Are patients with systemic lupus erythematosus at increased risk for COVID-19?","text":["Are patients with systemic lupus erythematosus at increased risk for COVID-19?","Ann Rheum Dis","Favalli, Ennio Giulio","Gerosa, Maria","Murgo, Antonella","Caporali, Roberto","32451344"],"journal":"Ann Rheum Dis","authors":["Favalli, Ennio Giulio","Gerosa, Maria","Murgo, Antonella","Caporali, Roberto"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451344","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/annrheumdis-2020-217787","keywords":["antirheumatic agents","hydroxychloroquine","lupus erythematosus, systemic"],"topics":["Prevention"],"weight":1,"_version_":1667983494599409664,"score":95.51595},{"pmid":32451345,"title":"Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.","text":["Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.","Ann Rheum Dis","Mathian, Alexis","Amoura, Zahir","32451345"],"journal":"Ann Rheum Dis","authors":["Mathian, Alexis","Amoura, Zahir"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451345","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/annrheumdis-2020-217859","keywords":["autoimmune diseases","hydroxychloroquine","lupus erythematosus, systemic"],"weight":0,"_version_":1667881798488555521,"score":90.29548}]}